Sylvia Nwosu

Sylvia Nwosu is Senior Director of the External Development Team in Bioproducts R&D at Eli Lilly & Company, where she leads global CDMO partnerships and oversees early-phase milestones across biologics and emerging modalities. With over 10 years of experience spanning small molecules, biologics, and ADCs, Dr. Nwosu specializes in designing phase-appropriate strategies that accelerate CMC timelines while optimizing resource utilization and execution efficiency. Dr. Nwosu holds a Ph.D. in Chemical Engineering from the University of Kansas and brings deep expertise in translating complex CMC challenges into actionable solutions that speed assets to the clinic.